Display Settings:

Format

Send to:

Choose Destination
Neurobiol Aging. 2011 Nov;32(11):1994-2005. doi: 10.1016/j.neurobiolaging.2009.12.016. Epub 2010 Jan 8.

Mutational screening and zebrafish functional analysis of GIGYF2 as a Parkinson-disease gene.

Author information

  • 1Dipartimento di Biologia e Genetica per le Scienze Mediche, Universit√† degli Studi di Milano, Milan, Italy.

Abstract

The Grb10-Interacting GYF Protein-2 (GIGYF2) gene has been proposed as the Parkinson-disease (PD) gene underlying the PARK11 locus. However, association of GIGYF2 with PD has been challenged and a functional validation of GIGYF2 mutations is lacking. In this frame, we performed a mutational screening of GIGYF2 in an Italian PD cohort. Exons containing known mutations were analyzed in 552 cases and 552 controls. Thereafter, a subset of 184 familial PD cases and controls were subjected to a full coding-exon screening. These analyses identified 8 missense variations in 9 individuals (4 cases, 5 controls). Furthermore, we developed a zebrafish model of gigyf2 deficiency. Abrogation of gigyf2 function in zebrafish embryos did not lead to a drastic cell loss in diencephalic dopaminergic (DA) neuron clusters, suggesting that gigyf2 is not required for DA neuron differentiation. Notably, gigyf2 functional abrogation did not increase diencephalic DA neurons susceptibility to the PD-inducing drug MPP+. These data, together with those recently reported by other groups, suggest that GIGYF2 is unlikely to be the PARK11 gene.

Copyright © 2009 Elsevier Inc. All rights reserved.

PMID:
20060621
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Write to the Help Desk